Digestive Diseases and Sciences

, Volume 33, Supplement 3, pp 71S–77S | Cite as

Neuropeptides, inflammation, and motility

  • Emeran A. Mayer
  • Helen Raybould
  • Christian Koelbel
Mediators of Inflammatory Bowel Disease

Abstract

Neurogenic inflammation is a reaction which includes vasodilation, plasma extravasation, and smooth muscle contraction elicited by activation of and release of mediators from unmyelinated afferent nerve endings. Further release of inflammatory mediators follows activation of axon collaterals associated with these afferent nerve endings as axon reflexes. Substance P, somatostatin, vasoactive intestinal polypeptide, and calcitonin generelated peptide are candidate mediators. Recent evidence suggests that several of these peptides may be colocalized either with one or more other peptides or with acetylcholine or noradrenalin. Communicating pathways exist between nerves within the mucosa and the muscle layers. Both long and short visceral reflexes occur. Inflammatory, mechanical, or chemical stimuli reaching the mucosa may release peptides from peripheral nerve endings. Thus neurogenic inflammation may be an important factor in inflammatory bowel disease.

Key words

substance P primary afferent nerves capsaicin 

References

  1. 1.
    Costa M, Furness JB: Nervous control of intestinal motility.In Handbook of Experimental Pharmacology. G Bertaccini (ed). Berlin, Springer, 1982, Chap 10Google Scholar
  2. 2.
    Costa M, Furness JB, Llewellyn-Smith IJ: Histochemistry of the enteric nervous system.In Physiology of the Gastrointestinal Tract, LR Johnson (ed). New York, Raven, 1987, Chap 1Google Scholar
  3. 3.
    Dockray GJ: Physiology of enteric neuropeptides.In Physiology of the Gastrointestinal Tract. LR Johnson (ed). New York, Raven, 1987, Chap 2Google Scholar
  4. 4.
    Furness JB, Costa M: Identification of gastrointestinal neurotransmitters.In Handbook of Experimental Pharmacology, Vol 59/1. G Bertaccini (ed). Berlin, Springer, 1982, Chap 11Google Scholar
  5. 5.
    Keast JR, Furness JB, Costa M: Distribution of certain peptide-containing nerve fibers and endocrine cells in the gastrointestinal mucosa in five mammalian species. J Comp Neurol 236:403–422, 1985PubMedGoogle Scholar
  6. 6.
    Morrison JFB: (1977) The afferent innervation of the gastrointestinal tract.In Nerves and the Gut. FP Brooks and PW Evers (eds). New Jersey, Charles B. Slack, 1977, pp 297–322Google Scholar
  7. 7.
    Hagermark O, Hokfelt T, Pernow B: Flare and itch induced by substance P in human skin. J Invest Dermatol 71:233–235, 1978PubMedGoogle Scholar
  8. 8.
    Lembeck F, Holzer P: Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 310:175–183, 1979Google Scholar
  9. 9.
    Lembeck F: Substance P and sensory neurones.In Substance P. Metabolism and Biological Actions. CC Jordan, P Oehme (eds). London, Taylor and Francis, 1985, pp 137–151Google Scholar
  10. 10.
    Levine JD, Moskowitz MA, Basbaum AI: The contribution of neurogenic inflammation in experimental arthritis. J Immunol 135:843s-846s, 1985PubMedGoogle Scholar
  11. 11.
    Lotz M, Carson DA, Vaughan JH: Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science 235:893–895, 1987PubMedGoogle Scholar
  12. 12.
    Mandahl A, Bill A: Ocular responses to antidromic trigeminal stimulation, intracameral prostaglandin E1 and E2, capsaicin and substance P. Acta Physiol Scand 112:331–338, 1981PubMedGoogle Scholar
  13. 13.
    Bartho L, Holzer P: Search for a physiological role of substance P in gastrointestinal motility. Neuroscience 16:1–32, 1985PubMedGoogle Scholar
  14. 14.
    Pernow B: Substand P. Pharmacol Rev 35:85–141, 1983PubMedGoogle Scholar
  15. 15.
    Pernow B: Sutstance P: Present status and future prospects.In Substance P. Metabolism and Biological Actions. CC Jordan, P Oehme (eds). London, Taylor and Francis, 1985, pp 187–196Google Scholar
  16. 16.
    Cervero F, McRitchie HA: Neonatal capsaicin does not affect unmyelinated efferent fibers of the autonomic nervous system: Functional evidence. Brain Res 239:283–288, 1982PubMedGoogle Scholar
  17. 17.
    Holzer P, Sametz W: Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 91:975–981, 1986PubMedGoogle Scholar
  18. 18.
    Chaudhary NA, Truelove SC: Human colonic motility: A comparative study of normal subjects, patients with ulcerative colitis and the irritable bowel syndrome. Gastroenterology 40:11–17, 1961Google Scholar
  19. 19.
    Delbro D, Lisander B, Anderson SA: Atropine-sensitive gastric smooth muscle excitation by mucosal nociceptive stimulation—the involvement of an action reflex? Acta Physiol Scan 122:621–627, 1984Google Scholar
  20. 20.
    Fox-Robichaud AE, Collins SM: Altered calcium-handling properties of jejunal smooth muscle from the nematodeinfested rat. Gastroenterology 91:1462–1469, 1986PubMedGoogle Scholar
  21. 21.
    Garret JM, Sauer WG, Moertel CG: Colonic motility in ulcerative colitis after opiate administration. Gastroenterology 53:93–100, 1967PubMedGoogle Scholar
  22. 22.
    Garrick T, Leung FW, Buack S, Hirabayashi K, Guth PH: Gastric motility is stimulated but overall blood flow is unaffected during cold restraint in the rat. Gastroenterology 91:141–148, 1986PubMedGoogle Scholar
  23. 23.
    Higgs RH, Castell DO, Eastwood GL: Studies on the mechanism of esophagitis-induced lower esophageal sphincter hypotension in cats. Gastroenterology 71:51–56, 1976PubMedGoogle Scholar
  24. 24.
    Kern F Jr, Almy TP, Abbot FK, Boggdonoff MD: The motility of the distal colon in nonspecific ulcerative colitis. Gastroenterology 19:492–503, 1951PubMedGoogle Scholar
  25. 25.
    Mayer EA, Schuffler MD, Rotter JI, Hanna P, Mogard M: Familial visceral neuropathy with autosomal dominant transmission. Gastroenterology 91:1528–1535, 1986PubMedGoogle Scholar
  26. 26.
    Read NW: Diarrhee motrice.In Clinics in Gastroenterology, Vol 15/3. GJ Krejs (ed). Philadelphia, Saunders, 1986, Chap 10Google Scholar
  27. 27.
    Schuffler MD, Kaplan LR, Johnson L: Small intestinal mucosa in pseudo-obstruction syndromes. Am J Dig Dis 23:821–828, 1978PubMedGoogle Scholar
  28. 28.
    Snape WJ Jr, Matarazzo SA, Cohen S: Abnormal gastrocolonic response in patients with ulcerative colitis. Gut 21:392–396 1980PubMedGoogle Scholar
  29. 29.
    Spriggs EA, Code CF, Bargen JA, Curtiss RK, Hightower NC Jr: Motility of the pelvic colon and rectum of normal persons and patients with ulcerative colitis. Gastroenterology 19:480–491, 1951PubMedGoogle Scholar
  30. 30.
    Almy TP: Observations on the pathologic physiology of ulcerative colitis. Gastroenterology 40:299–306, 1961PubMedGoogle Scholar
  31. 31.
    Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A: Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 91:897–904, 1986PubMedGoogle Scholar
  32. 32.
    Sanders KM, Smith TK: Mononeurones of the submucous plexus regulate electrical activity of the circular muscle of canine proximmal colon. J Physiol 380:293–310, 1986PubMedGoogle Scholar
  33. 33.
    Costa M, Furness JB, Llewellyn-Smith IJ, Murphy R, Bornstein JC, Keast JR: Functional roles for substance P-containing neurones in the gastrointestinal tract.In Substance P. Metabolism and Biological Actions. CC Jordan, P Oehme (eds). London, Taylor and Francis, 1985, pp 99–119Google Scholar
  34. 34.
    Feher E, Burnstock G: Ultrastructural localization of substance P, vasoactive intestinal polypeptide, somatostatin and neuropeptide Y immunoreactivity in perivascular nerve plexuses of the gut. Blood vessels 23:125–136, 1986PubMedGoogle Scholar
  35. 35.
    Furness JB, Papka RE, Della NG, Costa M, Eskay RL: Substance P-like immunoreactivity in nerves associated with the vascular system of guinea-pigs. Neuroscience 7:447–459, 1982PubMedGoogle Scholar
  36. 36.
    Bartho L, Holzer P, Lembeck F, Szolcsanyi J: Evidence that the contractile response of the guinea-pig ileum to capsaicin is due to substance P. J Physiol 332:157–167, 1982PubMedGoogle Scholar
  37. 37.
    Wood JD: Physiology of the enteric neurons system.In Physiology of the Gastrointestinal Tract. LR Johnson (ed). New York, Raven, 1987, Chap 3Google Scholar
  38. 38.
    Buck SH, Burks TF: The neuropharmacology of capsaicin: Review of some recent observations. Pharmacol Rev 38:179–226, 1986PubMedGoogle Scholar
  39. 39.
    Lembeck F, Skotfish G: Visceral pain reflex after pretreatment with capsaicin and morphine. Naunyn-Schmiedebergs Arch Pharmacol 321:116–122, 1982PubMedGoogle Scholar
  40. 40.
    Lundberg JM, Brodin E, Hua X, Saria A: Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea pig. Acta Physiol Scand 120:217–227, 1984PubMedGoogle Scholar
  41. 41.
    Bartho L, Szolcsanyi J: Local chemoreflexes of the guinea Pig ileum elicitied by sensory stimulating agents. Acta Physiol Hung 52:200, 1978Google Scholar
  42. 42.
    Holzer P, Lippe IT, Holzer-Petsche V: Inhibition of gastrointestinal transit due to surgical trauma on peritoneal irritation is reduced in capsavesh-treated rate. Gastroenterology 91:360–336, 1986PubMedGoogle Scholar
  43. 43.
    Szolcsanyi J, Bartho L: Impaired defense mechanism to peptic ulcer in the capsaicin-desensitized rat.In Advances in Physiological Science, Vol 15, Gastrointestinal Defense Mechanisms. Mozsik, O Haenninen, T Javor (eds). New York, Pergamon Press, 1981, pp 39–51Google Scholar
  44. 44.
    Maggi CA, Manzini S, Giuliani S, Santicioli P, Meli A: Extrinsic origin of the capsaicin-sensitive innervation of rat duodenum: Possible involvement of calcitonin-gene-related peptide (CGRP) in the capsaicin-induced activation of intramural nonadrenergic noncholinergic neurons. NaunynSchmiedebergs Arch Pharmacol 334:172–180, 1986Google Scholar
  45. 45.
    Rozsa Z, A Varro, G Jansco: Use of immunoblockade to study the involvement of peptidergic afferent nerves in the intestinal vasodilating response to capsain in the day. Eur J Pharmacol 115:59–63, 1985PubMedGoogle Scholar
  46. 46.
    Gamse R, Lackner D, Gamse G, Leeman SE: Effect of capsaicin pretreatment on capsaicin-evoked release of immunoreactive somatostatin and substance P from primary sensory neurons. Naunyn-Schmiedebergs Arch Pharmacol 316:38–41, 1981PubMedGoogle Scholar
  47. 47.
    Lembeck F, Donnerer J: Opioid control of the function of primary afferent substance P fibres. Eur J Pharmacol 114:241–246, 1985PubMedGoogle Scholar
  48. 48.
    Lembeck F, Donnerer J, Bartho L: Inhibition of neurogenic vasodilatation and plasma extravasation by substance P antagonists, somatostatin and [D-MET2,PRO5]enkephalinamide. Eur J Pharmacol 85:171–176, 1982PubMedGoogle Scholar
  49. 49.
    Gamse R, Saria A: Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol 114:61–66, 1985PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Emeran A. Mayer
    • 1
    • 2
    • 3
  • Helen Raybould
    • 1
    • 2
    • 3
  • Christian Koelbel
    • 1
    • 2
    • 3
  1. 1.Department of Medicine, Division of GastroenterologyHarbor-UCLA Medical CenterTorrance
  2. 2.Center for Ulcer Research and EducationLos Angeles
  3. 3.Harbor/UCLA Inflammatory Bowel Disease CenterUSA

Personalised recommendations